In a study by Yujie Cheng, the oral administration of BCP prevented cognitive impairment in APP/PS1 mice, and this positive cognitive effect was associated with reduced β-amyloid burden in both hippocampus and cerebral cortex (Cheng et al., 2014). Here, APP is linked to Cognitive impairment.